SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China
4 references·1 citing·19 second hop
Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China (2021)Lowering drug prices and enhancing pharma…Pricing of pharmaceuticals is becoming a major challenge for health systems (2020)Pricing of pharmaceuticals is…10 years of health-care reform in China: progress and gaps in Universal Health Coverage (2019)10 years of health-care refor…Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries (2016)Access to Medications for Car…China statistical yearbook (1988)China statistical yearbookImproving access to medicines and beyond: the national volume-based procurement policy in China (2023)Improving access to medicines…A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial (2012)Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2014)Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015)Access to medicines through health systems in low- and middle-income countries (2019)Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability (2020)Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature (2021)The cost of drug development: A systematic review (2011)The $2.6 Billion Pill — Methodologic and Policy Considerations (2015)Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research (2016)Access and Unmet Needs of Orphan Drugs in 194 Countries and 6 Areas: A Global Policy Review With Content Analysis (2020)Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis (2008)Policy options for pharmaceutical pricing and purchasing: issues for low- and middle-income countries (2014)The impact of centralization on pharmaceutical procurement prices: the role of institutional quality and corruption (2015)Measuring Pro-Poor Growth (2001)Capitalism with Chinese Characteristics (2008)An optimal parameters-based geographical detector model enhances geographic characteristics of explanatory variables for spatial heterogeneity analysis: cases with different types of spatial data (2020)Does long-term care insurance reduce hospital utilization and medical expenditures? Evidence from China (2020)Towards universal health coverage: lessons from 10 years of healthcare reform in China (2020)Ten years of China’s new healthcare reform: a longitudinal study on changes in health resources (2021)
this work references cited by second hop

References

  • 1988China statistical yearbook12,378 cited
  • 201910 years of health-care reform in China: progress and gaps in Universal Health Coverage1,258 cited
  • 2016Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries185 cited
  • 2020Pricing of pharmaceuticals is becoming a major challenge for health systems145 cited

Cited by

  • 2023Improving access to medicines and beyond: the national volume-based procurement policy in China86 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work